Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina
Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

da admin | Dic 19, 2023 | RACCOLTA BIBLIOGRAFICA

Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways Zhijun Zhao, Yongqing Tong, Yuting Kang, Zhuoran Qiu, Qiujie Li, Chao Xu, Geng Wu, Wei Jia, Pengtao Wang Visualizza...
Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome

da admin | Dic 19, 2023 | RACCOLTA BIBLIOGRAFICA

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome Konrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, Mariusz Rosołowski, Grażyna Rydzewska Visualizza...
Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis – a prospective randomized study

da admin | Dic 19, 2023 | RACCOLTA BIBLIOGRAFICA

Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis – a prospective randomized study Lukasz Krokowicz, Zoran Stojcev, Bartosz Filip Kaczmarek, Wojciech Kociemba, Elżbieta Kaczmarek, Jaroslaw...
Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

da admin | Dic 19, 2023 | RACCOLTA BIBLIOGRAFICA

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease Sonia Facchin, Nicola Vitulo, Matteo Calgaro, Andrea Buda, Chiara Romualdi, Daniel Pohl, Barbara Perini, Greta Lorenzon, Carla Marinelli, Renata D’Incà, Giacomo...
Sodium butyrate (SB) ameliorated inflammation of COPD induced by cigarette smoke through activating the GPR43 to inhibit NF-κB/MAPKs signaling pathways

Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion

da admin | Dic 19, 2023 | RACCOLTA BIBLIOGRAFICA

Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion Min Zhuang, Wenting Shang, Qiuchen Ma, Padraig Strappe, and Zhongkai Zhou Visualizza...
« Post precedenti
Post successivi »

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it